Abstract:Early precise diagnosis of cancers is crucial to realize more effective therapeutic interventions with minimal toxic effects. Cancer phenotypes may also alter greatly among patients and within individuals over therapeutic process. The identification and characterization of specific biomarkers expressed on tumor cells are highly demanded for diagnosis and treatment, but remain ongoing challenge. Herein, we designed three new bioorthogonal surface enhanced Raman scattering (SERS) nanoprobes and successfully applied the cocktail of them for MDA-MB-231 and MCF-7 breast cancer multiplex phenotype detection. The SERS nanoprobes containing Raman reporters with diynl, azide or cyano moieties demonstrated apparent Raman shift peaks in 2205 cm-1, 2120 cm-1 and 2230 cm-1, respectively, in biologically Raman-silent region. Three target ligands including oligonucleotide aptamer (AS1411), arginine-glycine-aspatic acid (RGD) peptide and homing cell adhesion molecule antibody (anti-CD44) were respectively conjugated to the nanoprobes for active recognition capability. The cocktail of the nanoprobes manifested minimal cytotoxicity and simultaneously multiplex phenotype imaging of MDA-MB-231 and MCF-7 cells. Quantitative measurement of cellular uptake by in-ductively coupled plasma mass spectrometry (ICP-MS) verified that MDA-MB-231 cells harbored much higher expres-sion level of CD44 receptor than MCF-7 cells. For in vivo SERS detection, Raman shift peaks of 2120 cm-1, 2205 cm-1 and 2230 cm-1 in micro tumor were clearly observed, representing the existence of three specific biomarkers of nucleolin, integrin αvβ3 and CD44 reporter, which could be used for early cancer phenotype identification. The biodistribution results indicated that target ligand modified nanoprobes exhibited much more accumulation in tumors than those nanoprobes without target ligands. The multicolor cocktail of bioorthogonal SERS nanoprobes offers an attractive and insightful strategy for early cancer multiplex phenotype targeting and diagnosis in vivo with non-invasion, low cross-talk, unique spectral-molecular signature, high sensitivity and negligible background interference.

Nanopipette-Based SERS Aptasensor for Subcellular Localization of Cancer Biomarker in Single Cells.

SERS Nanoprobes in Biologically Raman Silent Region for Tumor Cell Imaging and in Vivo Tumor Spectral Detection in Mice

Monodisperse Au@Ag core-shell nanoprobes with ultrasensitive SERS-activity for rapid identification and Raman imaging of living cancer cells.

Distinguishing Cancer Cell Lines at Asingle Living Cell Level Via Detection of Sialic Acid by Dual-Channel Plasmonic Imaging and by Using a SERS-microfluidic Droplet Platform

Ultrasensitive plasmon enhanced Raman scattering detection of nucleolin using nanochannels of 3D hybrid plasmonic metamaterial

Bioorthogonal Surface-Enhanced Raman Scattering Flower-Like Nanoprobe with Embedded Standards for Accurate Cancer Cell Imaging

Nanoparticle-aptamer conjugates for cancer cell targeting and detection.

DNA Self-Assembled Au Nanoparticle Clusters on Silver Nanorod Arrays for High-Sensitive and Multiplex Detection of Cancer-Related Biomarkers.

Highly Sensitive and Simultaneous Detection of Ctdnas Related to Non-Small Cell Lung Cancer in Serum Using a Catalytic Hairpin Assembly Strategy in a SERS Microfluidic Chip.

Identification and distinction of non-small-cell lung cancer cells by intracellular SERS nanoprobes

Gold Nanoparticle (Aunp)-Based Surface-Enhanced Raman Scattering (SERS) Probe of Leukemic Lymphocytes

Multicolor Cocktail for Breast Cancer Multiplex Phenotype Targeting and Diagnosis Using Bioorthogonal Surface-Enhanced Raman Scattering Nanoprobes.

Highly narrow nanogap-containing Au@Au core–shell SERS nanoparticles: size-dependent Raman enhancement and applications in cancer cell imaging

Target-triggered assembly of plasmon resonance nanostructures for quantitative detection of lncRNA in liver cancer cells via surface enhanced Raman spectroscopy

Highly accurate and label-free discrimination of single cancer cell using a plasmonic oxide-based nanoprobe

Using Aptamer–Nanoparticle Conjugates for Cancer Cells Detection

SPR/SERS dual-mode plasmonic biosensor via catalytic hairpin assembly-induced AuNP network

Surface Enhanced Raman Scattering Probes Based on Antibody Conjugated Au Nanostars for Distinguishing Lung Cancer Cells from Normal Cells

In Situ, Accurate, Surface-Enhanced Raman Scattering Detection of Cancer Cell Nucleus with Synchronous Location by an Alkyne-Labeled Biomolecular Probe

Fine Synthesis of Prussian-blue Analogue Coated Gold Nanoparticles (au@pba NPs) for Sorting Specific Cancer Cell Subtypes.

Electroporation-Assisted Surface-Enhanced Raman Detection for Long-Term, Label-Free, and Noninvasive Molecular Profiling of Live Single Cells